4.4 Review

Cancer stem cells: a model in the making

期刊

出版社

CURRENT BIOLOGY LTD
DOI: 10.1016/j.gde.2008.12.003

关键词

-

资金

  1. Novartis Pharmaceuticals, Inc.
  2. National Cancer Institute [CA89393, CA94074]
  3. Department of Defense [W81XWH-04-1-0452]

向作者/读者索取更多资源

Cancer stem cells and their potential roles in tumor heterogeneity are currently subjects of intense investigation. Studies suggest that these cells may develop from any normal cell and have begun to elucidate their molecular profiles. The percentage of a tumor composed of cancer stem cells varies greatly, and researchers believe that multiple types of these cells may exist in a single neoplasm. Cancer stem cells may be formed by epithelial-mesenchymal transition and seem to be less prevalent in metastases than in corresponding primary tumors. These cells appear to have therapeutic sensitivities different from those of cancer cells with more differentiated features. Looking into the many questions that remain about the cancer stem cells model might lead to more effective cancer prevention, diagnosis, and treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据